Management Team
Amy Tseng, MBA, CPA
President
An accomplished CPA with experience at both Ernst & Young and Price Waterhouse, Ms. Amy Tseng founded Bio-Tissue in 1997 with the vision of re-introducing amniotic membrane as a platform technology for the treatment of ocular surface diseases. Since its inception, Ms. Tseng has carried this mission, building Bio-Tissue into the industry leader. Through excellent financial and corporate management, she has guided Bio-Tissue through impressive levels of annual growth.
In addition to her instrumental role in founding the company, Ms. Tseng continues to lead and drive the company not only to provide the highest quality product possible, but also to continuously improve methods of wound care management.
Ms. Tseng graduated from the National Taiwan University and received her MBA from the University of Southern California. She is also certified as a CPA in several states, including Florida and California.
Andy Wasserman
Vice President of Sales & Marketing
Leveraging over 15 years of sales leadership experience, Mr. Andy Wasserman oversees the sales and marketing efforts by leading sales management, product development, and promotion initiatives for Bio-Tissue’s emerging technology. By managing infrastructure to maximize sales efforts and market space penetration, Mr. Wasserman is constantly pushing Bio-Tissue to the next horizon of achievements in sales and marketing.
Prior to joining Bio-Tissue, Mr. Wasserman was the National Sales Manager for OptiMedica, Inc., where he was responsible for the successful launch of the company’s flagship pattern scanning laser technology for the treatment of retinal diseases. Previously, he held sales and sales management positions at several prestigious ophthalmology companies, including Coherent Medical Group (Lumenis, Inc.) and Storz Ophthalmics (Bausch and Lomb).
At Coherent Medical Group, Mr. Wasserman played a pivotal role in the launch of two major products: the PDT (Photodynamic Therapy) laser for wet macular degeneration and the SLT (Selective Laser Trabeculoplasty) laser for the treatment of primary open angle glaucoma.
Topaz Kirlew
MT(ASCP), MBA, DBA
Executive Vice President Technical & Regulatory Affairs
Dr. Kirlew has over 20 years of scientific, professional and management experience in the medical, manufacturing and service environments. Dr. Kirlew is an operations-oriented leader with formal scientific and business training. She received a Bachelor of Science degree in Medical Technology from Florida International University in 1986 and a Masters in Business Administration degree from Nova Southeastern University in 1997. In 2008, she received her Doctorate in Business Administration with a specialty in Health Sciences from Nova Southeastern University.
Before joining Bio-Tissue in 2004, Dr. Kirlew headed the Clinical & Regulatory Affairs operations at a biotech company in Florida where Phase I & Phase II cell therapy and medical device clinical trials were underway in the US and Europe. Prior to this appointment, she worked with the University of Miami, School of Medicine, Diabetes Research Institute as the Program Manager of the cGMP Human Cell Processing Facility. During her five-year tenure with the University of Miami, Dr. Kirlew set up a GMP facility and was the pioneer in setting manufacturing, quality and regulatory standards for the field of human pancreatic islet transplantation. She moved the program from the research stage through Phases I, II & III of clinical trials. Additionally, she was actively involved in assisting various other centers worldwide in their efforts to set up GMP facilities. Dr. Kirlew has worked with the FDA and other industry organizations to help set regulatory and quality standards for the field of cellular therapy that have been benchmarked and adopted worldwide. Prior to working with the University of Miami, she worked at institutions such as the National Institutes of Health, Georgetown University Hospital, University of Maryland Medical Center and the American Red Cross.